AI Summary
✦ ClarthaPrice Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
From 14 analysts
Fundamentals
Fundamentals institutional score is 42 using growth durability 42.3.
Valuation
Valuation institutional score is 96 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
Analyst View institutional score is 58 using mean target upside 18.3%; dispersion penalty 25.2; recommendation breadth from available consensus.
Technical Structure
Technicals institutional score is 25 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
Recent news flow is balanced or not decisive enough to tilt the tape. Based on 10 recent ticker-linked news items.
Signal Summary
Market intelligence remains Neutral. valuation and market sentiment provide support, while fundamentals and technical structure remain considerations.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Trading 37.5% below historical median. Valuation is declining — currently in the strongly undervalued zone (z-score: -1.47). Confidence: 77%.
Live forward EPS implies next-12-month EPS of ₹32.26. Applying the stock's normalized valuation corridor produces a fair range of ₹1,356.86 to ₹2,101.09, with base value near ₹1,904.95 (+135.2% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹32.26
Forward P/E
25.1x
Base Fair Value
₹1,904.95
Fair Range
₹1,356.86 - ₹2,101.09
Upside To Base
+135.2%
Estimate Source
Live forward EPS
Growth Estimate
+4.7%
5Y Average
63.16
Current
36.92
Overvalued
65.13
Undervalued
42.06
5Y Average
39.75
Current
23.23
Overvalued
44.25
Undervalued
33.90
5Y Average
7.15
Current
5.44
Overvalued
8.76
Undervalued
5.44
Peers & Comparison
Sector: Materials · Theme: Specialty Chemicals
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
SUPREME PETROCHEM LIMITED SPLPETROSpecialty Chemicals | +23.7% | 8.5% | 26.5x Undervalued | -54% vs avg | -4.8% |
FINE ORGANIC IND. LTD. FINEORGSpecialty Chemicals | +22.1% | 17.8% | 35.9x Undervalued | -38% vs avg | +3.6% |
ALKYL AMINES CHEM. LTD ALKYLAMINESpecialty Chemicals | -4.6% | 11.8% | 44.4x Undervalued | -23% vs avg | -7.6% |
GALAXY SURFACTANTS LTD GALAXYSURFSpecialty Chemicals | +14.8% | 5.1% | 27.1x Undervalued | -53% vs avg | -11.6% |
NAVIN FLUORINE INT. LTD NAVINFLUORSpecialty Chemicals | +44.1% | 21.7% | 52.9x Fair | -8% vs avg | +67.4% |
ANUPAM RASAYAN INDIA LTD ANURASSpecialty Chemicals | +27.5% | 7.2% | 78.3x Premium | +35% vs avg | +6.9% |
FINEOTEX CHEMICAL LIMITED FCLSpecialty Chemicals | +174.8% | 12.1% | 104.9x Premium | +81% vs avg | +86.4% |
AETHER INDUSTRIES LIMITED AETHERSpecialty Chemicals | +27.5% | 19.1% | 92.2x Premium | +60% vs avg | +117.2% |
CLEAN SCIENCE & TECH LTD trades at a discount (36.9x vs peer avg 57.8x), suggesting potential undervaluation relative to the Specialty Chemicals cohort. Peers include SUPREME PETROCHEM LIMITED, FINE ORGANIC IND. LTD., ALKYL AMINES CHEM. LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹207 CrJun 2026Latest net profit
₹73 CrJun 2026Latest EPS
₹6.90Jun 2026Net margin
42.0%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 188 | 181 | 195 | 225 | 217 | 228 | 232 | 245 | 220 | 213 | 185 | 197 | 207 |
| Expenses + | 112 | 106 | 108 | 127 | 120 | 133 | 129 | 141 | 119 | 121 | 113 | 109 | 120 |
| Operating Profit | 77 | 76 | 86 | 99 | 98 | 95 | 102 | 105 | 101 | 92 | 72 | 88 | 87 |
| OPM % | 41% | 42% | 44% | 44% | 45% | 41% | 44% | 43% | 46% | 43% | 39% | 45% | 42% |
| Other Income + | 12 | 5 | 8 | 13 | 10 | 10 | 5 | 12 | 13 | 6 | 9 | 0 | 21 |
| Interest | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Profit before tax | 78 | 69 | 83 | 101 | 96 | 94 | 96 | 105 | 102 | 86 | 70 | 77 | 98 |
| Tax % | 25% | 25% | 25% | 26% | 25% | 28% | 22% | 25% | 25% | 25% | 26% | 25% | 25% |
| Net Profit + | 59 | 52 | 62 | 75 | 72 | 67 | 74 | 79 | 77 | 65 | 52 | 58 | 73 |
| EPS in Rs | 5.51 | 4.89 | 5.87 | 7.04 | 6.79 | 6.35 | 6.97 | 7.40 | 7.21 | 6.08 | 4.88 | 5.47 | 6.90 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome